nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—GABRR3—retina—malignant glioma	0.0107	0.0273	CbGeAlD
Triazolam—GABRQ—telencephalon—malignant glioma	0.00982	0.0252	CbGeAlD
Triazolam—GABRR2—retina—malignant glioma	0.00926	0.0237	CbGeAlD
Triazolam—GABRR1—retina—malignant glioma	0.00891	0.0228	CbGeAlD
Triazolam—TSPO—blood vessel—malignant glioma	0.00875	0.0224	CbGeAlD
Triazolam—Memory impairment—Temozolomide—malignant glioma	0.00806	0.0306	CcSEcCtD
Triazolam—GABRA6—brainstem—malignant glioma	0.00768	0.0197	CbGeAlD
Triazolam—Thinking abnormal—Carmustine—malignant glioma	0.00715	0.0272	CcSEcCtD
Triazolam—GABRD—telencephalon—malignant glioma	0.00712	0.0182	CbGeAlD
Triazolam—GABRG1—telencephalon—malignant glioma	0.00686	0.0176	CbGeAlD
Triazolam—GABRA6—telencephalon—malignant glioma	0.00682	0.0175	CbGeAlD
Triazolam—Coordination abnormal—Carmustine—malignant glioma	0.00666	0.0253	CcSEcCtD
Triazolam—GABRB1—telencephalon—malignant glioma	0.00665	0.017	CbGeAlD
Triazolam—Hearing impaired—Temozolomide—malignant glioma	0.00664	0.0253	CcSEcCtD
Triazolam—GABRA5—telencephalon—malignant glioma	0.00661	0.0169	CbGeAlD
Triazolam—Coordination abnormal—Temozolomide—malignant glioma	0.00644	0.0245	CcSEcCtD
Triazolam—Depressed level of consciousness—Carmustine—malignant glioma	0.00632	0.024	CcSEcCtD
Triazolam—Depressed level of consciousness—Temozolomide—malignant glioma	0.00611	0.0232	CcSEcCtD
Triazolam—GABRA4—telencephalon—malignant glioma	0.006	0.0154	CbGeAlD
Triazolam—Mental disability—Carmustine—malignant glioma	0.00568	0.0216	CcSEcCtD
Triazolam—GABRB2—brainstem—malignant glioma	0.00565	0.0145	CbGeAlD
Triazolam—GABRD—medulla oblongata—malignant glioma	0.0056	0.0143	CbGeAlD
Triazolam—GABRQ—central nervous system—malignant glioma	0.00558	0.0143	CbGeAlD
Triazolam—Mental disability—Temozolomide—malignant glioma	0.00549	0.0209	CcSEcCtD
Triazolam—GABRG1—medulla oblongata—malignant glioma	0.00539	0.0138	CbGeAlD
Triazolam—GABRB1—medulla oblongata—malignant glioma	0.00522	0.0134	CbGeAlD
Triazolam—TSPO—embryo—malignant glioma	0.00522	0.0134	CbGeAlD
Triazolam—GABRA2—brainstem—malignant glioma	0.00517	0.0132	CbGeAlD
Triazolam—Deafness—Temozolomide—malignant glioma	0.00513	0.0195	CcSEcCtD
Triazolam—GABRD—midbrain—malignant glioma	0.00511	0.0131	CbGeAlD
Triazolam—Hepatic failure—Temozolomide—malignant glioma	0.00511	0.0194	CcSEcCtD
Triazolam—Amnesia—Carmustine—malignant glioma	0.00506	0.0192	CcSEcCtD
Triazolam—GABRG2—telencephalon—malignant glioma	0.00502	0.0129	CbGeAlD
Triazolam—GABRB2—telencephalon—malignant glioma	0.00502	0.0129	CbGeAlD
Triazolam—GABRA1—brainstem—malignant glioma	0.00499	0.0128	CbGeAlD
Triazolam—GABRG1—midbrain—malignant glioma	0.00492	0.0126	CbGeAlD
Triazolam—GABRG3—central nervous system—malignant glioma	0.00489	0.0125	CbGeAlD
Triazolam—Amnesia—Temozolomide—malignant glioma	0.00489	0.0186	CcSEcCtD
Triazolam—GABRG1—spinal cord—malignant glioma	0.0048	0.0123	CbGeAlD
Triazolam—TSPO—brainstem—malignant glioma	0.00478	0.0123	CbGeAlD
Triazolam—GABRB1—midbrain—malignant glioma	0.00477	0.0122	CbGeAlD
Triazolam—GABRR2—cerebellum—malignant glioma	0.00473	0.0121	CbGeAlD
Triazolam—GABRR1—central nervous system—malignant glioma	0.00466	0.0119	CbGeAlD
Triazolam—GABRB1—spinal cord—malignant glioma	0.00466	0.0119	CbGeAlD
Triazolam—TSPO—retina—malignant glioma	0.00461	0.0118	CbGeAlD
Triazolam—GABRA2—telencephalon—malignant glioma	0.00458	0.0117	CbGeAlD
Triazolam—Affect lability—Temozolomide—malignant glioma	0.00452	0.0172	CcSEcCtD
Triazolam—Ataxia—Carmustine—malignant glioma	0.00447	0.017	CcSEcCtD
Triazolam—GABRQ—brain—malignant glioma	0.00443	0.0114	CbGeAlD
Triazolam—GABRA1—telencephalon—malignant glioma	0.00443	0.0113	CbGeAlD
Triazolam—Mood swings—Temozolomide—malignant glioma	0.00435	0.0165	CcSEcCtD
Triazolam—Ataxia—Temozolomide—malignant glioma	0.00432	0.0164	CcSEcCtD
Triazolam—TSPO—telencephalon—malignant glioma	0.00424	0.0109	CbGeAlD
Triazolam—Muscular weakness—Carmustine—malignant glioma	0.00419	0.0159	CcSEcCtD
Triazolam—Muscular weakness—Temozolomide—malignant glioma	0.00405	0.0154	CcSEcCtD
Triazolam—GABRD—central nervous system—malignant glioma	0.00405	0.0104	CbGeAlD
Triazolam—GABRD—cerebellum—malignant glioma	0.00396	0.0101	CbGeAlD
Triazolam—GABRG2—medulla oblongata—malignant glioma	0.00394	0.0101	CbGeAlD
Triazolam—GABRB2—medulla oblongata—malignant glioma	0.00394	0.0101	CbGeAlD
Triazolam—GABRG1—central nervous system—malignant glioma	0.0039	0.00998	CbGeAlD
Triazolam—GABRG3—brain—malignant glioma	0.00388	0.00994	CbGeAlD
Triazolam—GABRA6—central nervous system—malignant glioma	0.00387	0.00992	CbGeAlD
Triazolam—Sweating increased—Temozolomide—malignant glioma	0.00386	0.0147	CcSEcCtD
Triazolam—GABRB3—telencephalon—malignant glioma	0.00385	0.00987	CbGeAlD
Triazolam—GABRG1—cerebellum—malignant glioma	0.00381	0.00976	CbGeAlD
Triazolam—GABRA6—cerebellum—malignant glioma	0.00379	0.0097	CbGeAlD
Triazolam—GABRB1—central nervous system—malignant glioma	0.00378	0.00968	CbGeAlD
Triazolam—GABRA5—central nervous system—malignant glioma	0.00376	0.00963	CbGeAlD
Triazolam—Dysuria—Temozolomide—malignant glioma	0.00371	0.0141	CcSEcCtD
Triazolam—GABRR1—brain—malignant glioma	0.0037	0.00947	CbGeAlD
Triazolam—GABRB1—cerebellum—malignant glioma	0.00369	0.00946	CbGeAlD
Triazolam—GABRG2—midbrain—malignant glioma	0.0036	0.00923	CbGeAlD
Triazolam—GABRB2—midbrain—malignant glioma	0.0036	0.00923	CbGeAlD
Triazolam—Stomatitis—Carmustine—malignant glioma	0.00357	0.0136	CcSEcCtD
Triazolam—GABRB2—spinal cord—malignant glioma	0.00352	0.00901	CbGeAlD
Triazolam—GABRG2—spinal cord—malignant glioma	0.00352	0.00901	CbGeAlD
Triazolam—GABRA3—central nervous system—malignant glioma	0.0035	0.00896	CbGeAlD
Triazolam—GABRA1—medulla oblongata—malignant glioma	0.00348	0.00892	CbGeAlD
Triazolam—Stomatitis—Temozolomide—malignant glioma	0.00345	0.0131	CcSEcCtD
Triazolam—GABRA4—central nervous system—malignant glioma	0.00341	0.00873	CbGeAlD
Triazolam—TSPO—medulla oblongata—malignant glioma	0.00333	0.00854	CbGeAlD
Triazolam—GABRA4—cerebellum—malignant glioma	0.00333	0.00854	CbGeAlD
Triazolam—Hallucination—Carmustine—malignant glioma	0.00327	0.0124	CcSEcCtD
Triazolam—GABRD—brain—malignant glioma	0.00321	0.00823	CbGeAlD
Triazolam—GABRA1—midbrain—malignant glioma	0.00318	0.00815	CbGeAlD
Triazolam—Visual impairment—Carmustine—malignant glioma	0.00317	0.012	CcSEcCtD
Triazolam—Hallucination—Temozolomide—malignant glioma	0.00316	0.012	CcSEcCtD
Triazolam—GABRA1—spinal cord—malignant glioma	0.0031	0.00795	CbGeAlD
Triazolam—GABRG1—brain—malignant glioma	0.00309	0.00792	CbGeAlD
Triazolam—GABRA6—brain—malignant glioma	0.00308	0.00788	CbGeAlD
Triazolam—Visual impairment—Temozolomide—malignant glioma	0.00306	0.0116	CcSEcCtD
Triazolam—Clotiazepam—CYP2C18—malignant glioma	0.00306	0.161	CrCbGaD
Triazolam—TSPO—midbrain—malignant glioma	0.00305	0.00781	CbGeAlD
Triazolam—GABRB3—medulla oblongata—malignant glioma	0.00303	0.00776	CbGeAlD
Triazolam—GABRB1—brain—malignant glioma	0.003	0.00768	CbGeAlD
Triazolam—GABRA5—brain—malignant glioma	0.00298	0.00764	CbGeAlD
Triazolam—TSPO—spinal cord—malignant glioma	0.00297	0.00762	CbGeAlD
Triazolam—Tinnitus—Temozolomide—malignant glioma	0.00296	0.0113	CcSEcCtD
Triazolam—Clobazam—CYP2C18—malignant glioma	0.00289	0.152	CrCbGaD
Triazolam—Erythema—Carmustine—malignant glioma	0.00286	0.0109	CcSEcCtD
Triazolam—GABRB2—central nervous system—malignant glioma	0.00285	0.00731	CbGeAlD
Triazolam—GABRG2—central nervous system—malignant glioma	0.00285	0.00731	CbGeAlD
Triazolam—GABRG2—cerebellum—malignant glioma	0.00279	0.00714	CbGeAlD
Triazolam—GABRB2—cerebellum—malignant glioma	0.00279	0.00714	CbGeAlD
Triazolam—GABRA3—brain—malignant glioma	0.00278	0.00712	CbGeAlD
Triazolam—GABRB3—midbrain—malignant glioma	0.00277	0.00709	CbGeAlD
Triazolam—Erythema—Temozolomide—malignant glioma	0.00276	0.0105	CcSEcCtD
Triazolam—Dysgeusia—Temozolomide—malignant glioma	0.00271	0.0103	CcSEcCtD
Triazolam—GABRA4—brain—malignant glioma	0.00271	0.00693	CbGeAlD
Triazolam—GABRB3—spinal cord—malignant glioma	0.0027	0.00692	CbGeAlD
Triazolam—Tremor—Carmustine—malignant glioma	0.00268	0.0102	CcSEcCtD
Triazolam—Agitation—Carmustine—malignant glioma	0.00263	0.00999	CcSEcCtD
Triazolam—GABRA2—central nervous system—malignant glioma	0.00261	0.00668	CbGeAlD
Triazolam—Tremor—Temozolomide—malignant glioma	0.00259	0.00984	CcSEcCtD
Triazolam—GABRE—central nervous system—malignant glioma	0.00258	0.00662	CbGeAlD
Triazolam—Ill-defined disorder—Temozolomide—malignant glioma	0.00257	0.00975	CcSEcCtD
Triazolam—GABRA2—cerebellum—malignant glioma	0.00255	0.00652	CbGeAlD
Triazolam—Agitation—Temozolomide—malignant glioma	0.00254	0.00966	CcSEcCtD
Triazolam—GABRA1—central nervous system—malignant glioma	0.00252	0.00645	CbGeAlD
Triazolam—Malaise—Temozolomide—malignant glioma	0.00249	0.00948	CcSEcCtD
Triazolam—Hypertension—Carmustine—malignant glioma	0.00247	0.00939	CcSEcCtD
Triazolam—GABRA1—cerebellum—malignant glioma	0.00246	0.00631	CbGeAlD
Triazolam—Palpitations—Temozolomide—malignant glioma	0.00244	0.00929	CcSEcCtD
Triazolam—Chest pain—Carmustine—malignant glioma	0.00244	0.00926	CcSEcCtD
Triazolam—Anxiety—Carmustine—malignant glioma	0.00243	0.00922	CcSEcCtD
Triazolam—TSPO—central nervous system—malignant glioma	0.00241	0.00618	CbGeAlD
Triazolam—Hypertension—Temozolomide—malignant glioma	0.00239	0.00907	CcSEcCtD
Triazolam—TSPO—cerebellum—malignant glioma	0.00236	0.00604	CbGeAlD
Triazolam—Confusional state—Carmustine—malignant glioma	0.00235	0.00895	CcSEcCtD
Triazolam—Anxiety—Temozolomide—malignant glioma	0.00235	0.00891	CcSEcCtD
Triazolam—Oedema—Carmustine—malignant glioma	0.00233	0.00887	CcSEcCtD
Triazolam—Discomfort—Temozolomide—malignant glioma	0.00233	0.00884	CcSEcCtD
Triazolam—Dry mouth—Temozolomide—malignant glioma	0.0023	0.00875	CcSEcCtD
Triazolam—Tachycardia—Carmustine—malignant glioma	0.00228	0.00866	CcSEcCtD
Triazolam—Confusional state—Temozolomide—malignant glioma	0.00228	0.00865	CcSEcCtD
Triazolam—Clotiazepam—CYP2B6—malignant glioma	0.00227	0.119	CrCbGaD
Triazolam—GABRG2—brain—malignant glioma	0.00226	0.0058	CbGeAlD
Triazolam—GABRB2—brain—malignant glioma	0.00226	0.0058	CbGeAlD
Triazolam—Oedema—Temozolomide—malignant glioma	0.00226	0.00858	CcSEcCtD
Triazolam—Anorexia—Carmustine—malignant glioma	0.00223	0.00846	CcSEcCtD
Triazolam—GABRB3—central nervous system—malignant glioma	0.00219	0.00561	CbGeAlD
Triazolam—Hyperhidrosis—Temozolomide—malignant glioma	0.00218	0.00829	CcSEcCtD
Triazolam—Anorexia—Temozolomide—malignant glioma	0.00215	0.00817	CcSEcCtD
Triazolam—Clobazam—CYP2B6—malignant glioma	0.00214	0.113	CrCbGaD
Triazolam—GABRB3—cerebellum—malignant glioma	0.00214	0.00548	CbGeAlD
Triazolam—Insomnia—Carmustine—malignant glioma	0.00211	0.00803	CcSEcCtD
Triazolam—Paraesthesia—Carmustine—malignant glioma	0.0021	0.00797	CcSEcCtD
Triazolam—Dyspnoea—Carmustine—malignant glioma	0.00208	0.00791	CcSEcCtD
Triazolam—Somnolence—Carmustine—malignant glioma	0.00208	0.00789	CcSEcCtD
Triazolam—GABRA2—brain—malignant glioma	0.00207	0.0053	CbGeAlD
Triazolam—GABRE—brain—malignant glioma	0.00205	0.00526	CbGeAlD
Triazolam—Insomnia—Temozolomide—malignant glioma	0.00204	0.00776	CcSEcCtD
Triazolam—Decreased appetite—Carmustine—malignant glioma	0.00203	0.00771	CcSEcCtD
Triazolam—Paraesthesia—Temozolomide—malignant glioma	0.00203	0.0077	CcSEcCtD
Triazolam—Dyspnoea—Temozolomide—malignant glioma	0.00201	0.00765	CcSEcCtD
Triazolam—Somnolence—Temozolomide—malignant glioma	0.00201	0.00762	CcSEcCtD
Triazolam—GABRA1—brain—malignant glioma	0.002	0.00512	CbGeAlD
Triazolam—Pain—Carmustine—malignant glioma	0.002	0.00759	CcSEcCtD
Triazolam—Constipation—Carmustine—malignant glioma	0.002	0.00759	CcSEcCtD
Triazolam—Flunitrazepam—CYP2B6—malignant glioma	0.00196	0.103	CrCbGaD
Triazolam—Decreased appetite—Temozolomide—malignant glioma	0.00196	0.00745	CcSEcCtD
Triazolam—Fatigue—Temozolomide—malignant glioma	0.00195	0.00739	CcSEcCtD
Triazolam—Constipation—Temozolomide—malignant glioma	0.00193	0.00733	CcSEcCtD
Triazolam—Pain—Temozolomide—malignant glioma	0.00193	0.00733	CcSEcCtD
Triazolam—Feeling abnormal—Carmustine—malignant glioma	0.00192	0.00731	CcSEcCtD
Triazolam—TSPO—brain—malignant glioma	0.00192	0.00491	CbGeAlD
Triazolam—Gastrointestinal pain—Carmustine—malignant glioma	0.00191	0.00726	CcSEcCtD
Triazolam—Feeling abnormal—Temozolomide—malignant glioma	0.00186	0.00707	CcSEcCtD
Triazolam—Abdominal pain—Carmustine—malignant glioma	0.00185	0.00702	CcSEcCtD
Triazolam—Gastrointestinal pain—Temozolomide—malignant glioma	0.00185	0.00701	CcSEcCtD
Triazolam—Abdominal pain—Temozolomide—malignant glioma	0.00178	0.00678	CcSEcCtD
Triazolam—GABRB3—brain—malignant glioma	0.00174	0.00445	CbGeAlD
Triazolam—Hypersensitivity—Carmustine—malignant glioma	0.00172	0.00654	CcSEcCtD
Triazolam—Diazepam—CYP2C18—malignant glioma	0.00169	0.0885	CrCbGaD
Triazolam—Asthenia—Carmustine—malignant glioma	0.00168	0.00637	CcSEcCtD
Triazolam—Hypersensitivity—Temozolomide—malignant glioma	0.00166	0.00632	CcSEcCtD
Triazolam—Asthenia—Temozolomide—malignant glioma	0.00162	0.00615	CcSEcCtD
Triazolam—Diarrhoea—Carmustine—malignant glioma	0.0016	0.00607	CcSEcCtD
Triazolam—Pruritus—Temozolomide—malignant glioma	0.0016	0.00607	CcSEcCtD
Triazolam—Dizziness—Carmustine—malignant glioma	0.00154	0.00587	CcSEcCtD
Triazolam—Diarrhoea—Temozolomide—malignant glioma	0.00154	0.00587	CcSEcCtD
Triazolam—Temazepam—CYP2B6—malignant glioma	0.00151	0.0791	CrCbGaD
Triazolam—Dizziness—Temozolomide—malignant glioma	0.00149	0.00567	CcSEcCtD
Triazolam—Vomiting—Carmustine—malignant glioma	0.00148	0.00564	CcSEcCtD
Triazolam—Dermatitis—Carmustine—malignant glioma	0.00147	0.00559	CcSEcCtD
Triazolam—Headache—Carmustine—malignant glioma	0.00146	0.00556	CcSEcCtD
Triazolam—Midazolam—CYP2B6—malignant glioma	0.00146	0.0767	CrCbGaD
Triazolam—Vomiting—Temozolomide—malignant glioma	0.00143	0.00545	CcSEcCtD
Triazolam—Dermatitis—Temozolomide—malignant glioma	0.00142	0.0054	CcSEcCtD
Triazolam—Headache—Temozolomide—malignant glioma	0.00141	0.00537	CcSEcCtD
Triazolam—Nausea—Carmustine—malignant glioma	0.00139	0.00527	CcSEcCtD
Triazolam—Nausea—Temozolomide—malignant glioma	0.00134	0.00509	CcSEcCtD
Triazolam—CYP2C8—brain—malignant glioma	0.00131	0.00337	CbGeAlD
Triazolam—Diazepam—CYP2B6—malignant glioma	0.00125	0.0657	CrCbGaD
Triazolam—CYP3A4—central nervous system—malignant glioma	0.00112	0.00287	CbGeAlD
Triazolam—Diazepam—PTGS1—malignant glioma	0.000824	0.0432	CrCbGaD
Triazolam—GABRA6—Neuronal System—BRAF—malignant glioma	0.000209	0.000637	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000207	0.000633	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000207	0.000631	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000206	0.000629	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—BRAF—malignant glioma	0.000206	0.000629	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000205	0.000627	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000204	0.000623	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000204	0.000622	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—RTEL1—malignant glioma	0.000201	0.000615	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.0002	0.000611	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—MDM2—malignant glioma	0.0002	0.000611	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000199	0.000609	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—GSTP1—malignant glioma	0.000199	0.000608	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000199	0.000607	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000197	0.0006	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000196	0.0006	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	0.000196	0.000599	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000196	0.000599	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000196	0.000598	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000195	0.000596	CbGpPWpGaD
Triazolam—GABRA1—Ion channel transport—RAF1—malignant glioma	0.000194	0.000593	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000193	0.00059	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000192	0.000588	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000192	0.000586	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000191	0.000584	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000191	0.000582	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00019	0.000582	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000188	0.000575	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—BRAF—malignant glioma	0.000188	0.000575	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000188	0.000574	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000188	0.000574	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000188	0.000573	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—STAT3—malignant glioma	0.000188	0.000573	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—MDM2—malignant glioma	0.000187	0.000573	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000187	0.000571	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—RAF1—malignant glioma	0.000187	0.000571	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000187	0.00057	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—MDM2—malignant glioma	0.000185	0.000564	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—COX8A—malignant glioma	0.000185	0.000564	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—RAF1—malignant glioma	0.000184	0.000562	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000184	0.000561	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—BRAF—malignant glioma	0.000183	0.000559	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000183	0.000558	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000181	0.000554	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.00018	0.00055	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.00018	0.000549	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—BRAF—malignant glioma	0.00018	0.000549	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000179	0.000547	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000178	0.000544	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—BRAF—malignant glioma	0.000177	0.000539	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—BRAF—malignant glioma	0.000175	0.000536	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000175	0.000534	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—MDM2—malignant glioma	0.000175	0.000534	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—RAF1—malignant glioma	0.000174	0.000532	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000174	0.000531	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—MDM2—malignant glioma	0.000173	0.000527	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—BRAF—malignant glioma	0.000172	0.000526	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—RAF1—malignant glioma	0.000172	0.000525	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000171	0.000521	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000171	0.000521	CbGpPWpGaD
Triazolam—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000165	0.000504	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000165	0.000503	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000164	0.000501	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000164	0.0005	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000162	0.000495	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.00016	0.000488	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—MDM2—malignant glioma	0.000158	0.000482	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—RAF1—malignant glioma	0.000157	0.00048	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ASMT—malignant glioma	0.000157	0.000479	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000157	0.000479	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000154	0.000471	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—MDM2—malignant glioma	0.000153	0.000468	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—RAF1—malignant glioma	0.000153	0.000467	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000153	0.000466	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—BRAF—malignant glioma	0.000151	0.00046	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—MDM2—malignant glioma	0.000151	0.00046	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—RAF1—malignant glioma	0.00015	0.000458	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000149	0.000455	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—MDM2—malignant glioma	0.000148	0.000452	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—BCAN—malignant glioma	0.000148	0.000451	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—RAF1—malignant glioma	0.000147	0.00045	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—MDM2—malignant glioma	0.000147	0.000449	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—RAF1—malignant glioma	0.000146	0.000447	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000144	0.000441	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—MDM2—malignant glioma	0.000144	0.000441	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—RAF1—malignant glioma	0.000144	0.000439	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000144	0.000439	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000139	0.000425	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—COX8A—malignant glioma	0.000133	0.000408	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000131	0.000399	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000128	0.000391	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—MDM2—malignant glioma	0.000126	0.000385	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—RAF1—malignant glioma	0.000126	0.000384	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000122	0.000373	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000122	0.000373	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	0.000121	0.000369	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—IDH2—malignant glioma	0.000119	0.000363	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000117	0.000357	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—COX8A—malignant glioma	0.000116	0.000353	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ASMT—malignant glioma	0.000113	0.000346	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000113	0.000346	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2B6—malignant glioma	0.000112	0.000342	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000108	0.00033	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000107	0.000326	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—BCAN—malignant glioma	0.000107	0.000326	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000105	0.000322	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000103	0.000316	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—IDH1—malignant glioma	0.000102	0.000312	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.0001	0.000307	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SPHK1—malignant glioma	9.9e-05	0.000302	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—RAF1—malignant glioma	9.89e-05	0.000302	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ASMT—malignant glioma	9.83e-05	0.0003	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2C18—malignant glioma	9.7e-05	0.000296	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	9.6e-05	0.000293	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—COX8A—malignant glioma	9.41e-05	0.000287	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—RAF1—malignant glioma	9.36e-05	0.000286	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—RAF1—malignant glioma	9.24e-05	0.000282	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—BCAN—malignant glioma	9.24e-05	0.000282	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—IDH2—malignant glioma	8.6e-05	0.000263	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	8.46e-05	0.000258	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	8.41e-05	0.000257	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	8.21e-05	0.000251	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2B6—malignant glioma	8.08e-05	0.000247	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	8.07e-05	0.000246	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ASMT—malignant glioma	8e-05	0.000244	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	7.93e-05	0.000242	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	7.87e-05	0.000241	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTT1—malignant glioma	7.84e-05	0.00024	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	7.82e-05	0.000239	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	7.73e-05	0.000236	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BCAN—malignant glioma	7.52e-05	0.00023	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—IDH2—malignant glioma	7.45e-05	0.000227	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—IDH1—malignant glioma	7.39e-05	0.000226	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS1—malignant glioma	7.35e-05	0.000224	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SPHK1—malignant glioma	7.15e-05	0.000219	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.02e-05	0.000214	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2C18—malignant glioma	7.01e-05	0.000214	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2B6—malignant glioma	7e-05	0.000214	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—BCHE—malignant glioma	6.83e-05	0.000209	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.76e-05	0.000206	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SLC5A5—malignant glioma	6.75e-05	0.000206	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—IDH1—malignant glioma	6.4e-05	0.000196	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—COX8A—malignant glioma	6.2e-05	0.000189	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SPHK1—malignant glioma	6.2e-05	0.000189	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2C18—malignant glioma	6.07e-05	0.000185	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—IDH2—malignant glioma	6.06e-05	0.000185	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.72e-05	0.000175	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.72e-05	0.000175	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2B6—malignant glioma	5.7e-05	0.000174	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTT1—malignant glioma	5.67e-05	0.000173	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—malignant glioma	5.44e-05	0.000166	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS1—malignant glioma	5.31e-05	0.000162	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAT—malignant glioma	5.29e-05	0.000162	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ASMT—malignant glioma	5.27e-05	0.000161	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.21e-05	0.000159	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—IDH1—malignant glioma	5.21e-05	0.000159	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SPHK1—malignant glioma	5.04e-05	0.000154	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.03e-05	0.000154	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NCOR1—malignant glioma	5e-05	0.000153	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BCAN—malignant glioma	4.96e-05	0.000151	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2C18—malignant glioma	4.94e-05	0.000151	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—BCHE—malignant glioma	4.94e-05	0.000151	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—malignant glioma	4.91e-05	0.00015	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC5A5—malignant glioma	4.88e-05	0.000149	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.66e-05	0.000142	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS1—malignant glioma	4.6e-05	0.000141	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.58e-05	0.00014	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—BCHE—malignant glioma	4.28e-05	0.000131	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.24e-05	0.00013	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC5A5—malignant glioma	4.23e-05	0.000129	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.1e-05	0.000125	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAV1—malignant glioma	4.07e-05	0.000124	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—IDH2—malignant glioma	4e-05	0.000122	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—malignant glioma	4e-05	0.000122	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4e-05	0.000122	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.96e-05	0.000121	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—malignant glioma	3.93e-05	0.00012	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAT—malignant glioma	3.82e-05	0.000117	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.76e-05	0.000115	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS1—malignant glioma	3.74e-05	0.000114	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.73e-05	0.000114	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CG—malignant glioma	3.71e-05	0.000113	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOR1—malignant glioma	3.61e-05	0.00011	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARG—malignant glioma	3.58e-05	0.000109	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BCHE—malignant glioma	3.48e-05	0.000106	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.45e-05	0.000105	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC5A5—malignant glioma	3.44e-05	0.000105	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—IDH1—malignant glioma	3.44e-05	0.000105	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—malignant glioma	3.4e-05	0.000104	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SPHK1—malignant glioma	3.33e-05	0.000102	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAT—malignant glioma	3.31e-05	0.000101	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CD—malignant glioma	3.26e-05	9.96e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.26e-05	9.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.25e-05	9.93e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.22e-05	9.84e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOR1—malignant glioma	3.13e-05	9.55e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAV1—malignant glioma	2.94e-05	8.99e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.84e-05	8.68e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—malignant glioma	2.82e-05	8.6e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.81e-05	8.58e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—malignant glioma	2.77e-05	8.46e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAT—malignant glioma	2.7e-05	8.23e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.68e-05	8.19e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—malignant glioma	2.64e-05	8.05e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARG—malignant glioma	2.59e-05	7.9e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAV1—malignant glioma	2.55e-05	7.79e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOR1—malignant glioma	2.55e-05	7.77e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS1—malignant glioma	2.47e-05	7.54e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTEN—malignant glioma	2.46e-05	7.5e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.44e-05	7.44e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.36e-05	7.2e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CG—malignant glioma	2.32e-05	7.09e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BCHE—malignant glioma	2.3e-05	7.01e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.27e-05	6.93e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARG—malignant glioma	2.24e-05	6.85e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAV1—malignant glioma	2.08e-05	6.34e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.05e-05	6.27e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.04e-05	6.23e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—malignant glioma	2.04e-05	6.22e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.98e-05	6.05e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.89e-05	5.77e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—malignant glioma	1.83e-05	5.58e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARG—malignant glioma	1.82e-05	5.57e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.78e-05	5.43e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAT—malignant glioma	1.78e-05	5.43e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTEN—malignant glioma	1.78e-05	5.42e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—malignant glioma	1.76e-05	5.38e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.73e-05	5.29e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOR1—malignant glioma	1.68e-05	5.13e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.66e-05	5.07e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTEN—malignant glioma	1.54e-05	4.7e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.45e-05	4.42e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—malignant glioma	1.44e-05	4.38e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—malignant glioma	1.42e-05	4.32e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAV1—malignant glioma	1.37e-05	4.18e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.25e-05	3.82e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTEN—malignant glioma	1.25e-05	3.82e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.25e-05	3.81e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARG—malignant glioma	1.2e-05	3.67e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.1e-05	3.35e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.08e-05	3.31e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—malignant glioma	1.02e-05	3.12e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CB—malignant glioma	9.55e-06	2.92e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—malignant glioma	9.46e-06	2.89e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—malignant glioma	8.86e-06	2.71e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—malignant glioma	8.83e-06	2.7e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTEN—malignant glioma	8.25e-06	2.52e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—malignant glioma	7.21e-06	2.2e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.82e-06	1.78e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—malignant glioma	4.76e-06	1.45e-05	CbGpPWpGaD
